跳至主要内容
临床试验/NCT06889636
NCT06889636进行中(未招募)不适用

Assessment of the Impact of Pharmaceutical Care on the Quality of Life in Conditions Related to Psychotropic Drug Use and Evaluation of the Intervention

University of Rijeka2 个研究点 分布在 1 个国家目标入组 97 人开始时间: 2021年12月1日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
97
试验地点
2
主要终点
Assessment of the quality of life in subjects using psycholeptics and psychoanaleptics

研究概览

简要总结

This study aims to assess and describe the impact of pharmaceutical care on identified drug-related problems (DRPs) in subjects using psycholeptics and psychoanaleptics in primary care, improving subjects' self-assessed quality of life (QoL)

The hypothesis of the study are:

  1. Side-effects are the most common DRPs in subjects using psychotropic medicines in primary care,
  2. Treatment effectiveness and safety affect the subjects´ QoL

详细描述

The study objectives are to:

  1. assess QoL in subjects using psycholeptics and psychoanaleptics,
  2. analyze identified DRPs and their causes in subjects using psycholeptics and psychoanaleptics
  3. evaluate the correlation between the type and total number of DRPs identified in a single subject with QoL,
  4. describe the impact of pharmacists´ intervention in the identification and resolution of the DRPs and their causes on subjects´ QoL.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult participants (years 18+)
  • Usage of psycholeptic or psychoanaleptic medicines
  • Residence in Istrian County (Croatia)

排除标准

  • Minor participants
  • Hospitalization during study participation
  • Unable to live by themselves
  • Unable to participate in study for 3 months

结局指标

主要结局

Assessment of the quality of life in subjects using psycholeptics and psychoanaleptics

时间窗: Prior and after the pharmacists' intervention during three months period.

A short version of the World Health Organization's quality of life questionnaire (WHOQOL-BREF questionnaire) is being used to assess subjects' QoL. The scale range is from 0 to 100. A higher score number indicates better QoL.

次要结局

  • Analysis of identified drug-related problems(During period of three months.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alena Tatarevic

Assessment of the impact of pharmaceutical care on the quality of life in conditions related to psychotropic drug use and evaluation of the intervention

University of Rijeka

研究点 (2)

Loading locations...

相似试验